S T C Salehiya Trading Pharmaceutical Import Profile — Saudi Arabia (DGFT 2022–2026)

Name: S T C Salehiya Trading Pharmaceutical Import Records from India — 3 Products, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

S T C Salehiya Trading — Pharmaceutical Importer Profile (2026) | 3 Products, $1.6M Trade | TransData Nexus

S T C Salehiya Trading

Pharmaceutical Importer · Saudi Arabia · Advanced Antibiotics Focus · $1.6M Total Trade · DGFT Verified

S T C Salehiya Trading is a pharmaceutical importer based in Saudi Arabia with a total trade value of $1.6M across 3 products in 2 therapeutic categories. Based on 51 verified import shipments from Indian Customs (DGFT) records, S T C Salehiya Trading is the #1 buyer in 1 product including Dacarbazine. S T C Salehiya Trading sources from 1 verified Indian supplier, with Venus Remedies Limited accounting for 100.0% of imports.

S T C Salehiya Trading — Import Portfolio & Supplier Network

S T C Salehiya Trading import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to S T C Salehiya Trading?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Venus Remedies Limited	$1.6M	135	100.0%

S T C Salehiya Trading sources from 1 verified Indian supplier across 132 distinct formulations. The sourcing is highly concentrated — Venus Remedies Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does S T C Salehiya Trading Import?

Formulation	Value	Ships
Meropenem 1.0 GM powder for solution forinjection or infusion ronem 1000MG	$100.0K	2
Ronem 1.0 GM meropenem 1000MG powder for solution for injection or infusion Each vial contains: active	$100.0K	2
Ceftriaxone for injection usp1000 mgeach 10 ML vial contains:ceftriaxone sodium USP equivalent to ceftriaxone 1000MG	$50.0K	1
Elores 1.5 g/ vial ceftriaxone/sulbactam 1.5 g/ vial powder for solution for	$50.0K	1
Elores 1.5g/ vialceftriaxone/sulbactam1.5g/ vial powder for SOL.for INJ./infusionb/no.x3gd024a,m/dt.07/23	$50.0K	1
Meropenem 1.0 GM powder for solution forinjection or inf. b.n.x3ga294b,md.07/23 ed.06/25,x3ha014a md.08/23	$50.0K	1
Meropenem 1.0 GM powder for solution forinjection or infusion.ronem 1000MG.b.no.x3ha014b manufacturing . dt.08/23 exp. dt.	$50.0K	1
Meropenem 1.0 GM powder for solution forinjection or infusion b.no.x3ia104bx3ia154a md.09/2023	$50.0K	1
Meropenem 1.0 GM powder for solution forinjection or infusion.b.no.x3ia164e x3ia174a. md. 09/23	$50.0K	1
Lastinem imipenem + cilastatin 500MG +500 MG powder for solution for	$50.0K	1
Ronem 500 MG meropenem 500MG powder forsolution for injection or infusion Each vial contains: active pharmaceutical	$50.0K	1
Meropenem 500 MG powder for solution forinj. or infusion.ronem 500 MG.b.no.x3ea273dmd.05/23ed.04/25.	$49.1K	1
Methotrexate injection USP 50 MG/2ML Each ML contains: methotrexate USP...25 MG	$47.6K	1
Methotrexate injection USP 500 MG/5 mleach ML contains:methotrexate USP...100mgb.n.x3ime022a md.09/2023	$40.3K	1
Dacarol dacarbazine for INJ. USP 200 mgdacarol 200mgb.no.x3hdr012i md.08/23ed.07/25.b.no.x3jdr012a md.10/23	$35.3K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Meropenem	Advanced Antibiotics	$1.4M	28	0.6%	11
2	Dacarbazine	Advanced Oncology	$91.2K	11	6.4%	1
3	Bleomycin	Advanced Oncology	$81.5K	12	1.5%	11

S T C Salehiya Trading imports 3 pharmaceutical products across 2 categories into Saudi Arabia totaling $1.6M. The company is the #1 buyer for 1 product: Dacarbazine.

S T C Salehiya Trading — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

S T C Salehiya Trading is a prominent pharmaceutical importer and distributor based in Riyadh, Saudi Arabia. The company specializes in sourcing and supplying finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, to meet the healthcare needs of the Saudi market. As a key player in the pharmaceutical supply chain, S T C Salehiya Trading collaborates with various international manufacturers to ensure a steady and reliable supply of essential medications.

The company operates under the umbrella of Salehiya Trading Company, a well-established entity in the Saudi healthcare sector. Salehiya Trading Company has a legacy of innovation and excellence, partnering with leading global brands to enhance the healthcare experience in Saudi Arabia. Their mission is to elevate the quality of healthcare by providing innovative solutions across various segments, from pharmacies to hospitals.

2Distribution Network

S T C Salehiya Trading's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Saudi Arabia. While specific warehouse locations are not publicly disclosed, the company maintains a robust logistics infrastructure capable of handling a diverse range of pharmaceutical products. This infrastructure supports the company's operations in major cities and regions, facilitating timely and reliable distribution to meet the demands of the Saudi healthcare sector.

3Industry Role

In Saudi Arabia's pharmaceutical supply chain, S T C Salehiya Trading functions primarily as a pharmaceutical importer and distributor. The company sources finished pharmaceutical formulations from international suppliers, particularly from India, and supplies them to various stakeholders within the Saudi healthcare system, including hospitals, clinics, and pharmacies. By focusing on the importation and distribution of finished products, S T C Salehiya Trading plays a crucial role in ensuring the availability of essential medications in the Saudi market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — S T C Salehiya Trading

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

S T C Salehiya Trading exhibits a high degree of supplier concentration, sourcing all its pharmaceutical imports from a single supplier: Venus Remedies Limited. Between 2022 and 2026, the company imported finished pharmaceutical formulations worth $1.6 million USD from Venus Remedies Limited, encompassing 135 shipments. This exclusive sourcing strategy indicates a deep and stable relationship between S T C Salehiya Trading and Venus Remedies Limited, which can lead to favorable terms and consistent product quality.

However, this single-source dependency also presents potential risks. Any disruptions in Venus Remedies Limited's production or supply chain could directly impact S T C Salehiya Trading's ability to meet market demand. To mitigate such risks, it would be prudent for S T C Salehiya Trading to consider diversifying its supplier base, thereby enhancing supply chain resilience and reducing vulnerability to single-source disruptions.

2Supply Chain Resilience

The resilience of S T C Salehiya Trading's supply chain is closely tied to its exclusive partnership with Venus Remedies Limited. While this relationship ensures consistency in product quality and supply, it also means that the company is heavily reliant on a single supplier. In the event of production delays, quality issues, or logistical challenges faced by Venus Remedies Limited, S T C Salehiya Trading could experience significant disruptions in its supply chain.

Importing Pharmaceuticals into Saudi Arabia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Saudi Arabia

1Regulatory Authority & Framework

The Saudi Food and Drug Authority (SFDA) is the primary regulatory body overseeing the importation, registration, and distribution of pharmaceutical products in Saudi Arabia. The SFDA ensures that all pharmaceutical products meet the required safety, efficacy, and quality standards before they are permitted for sale in the Kingdom. (sfda.gov.sa)

Key legislation governing pharmaceutical imports includes the "Implementing Regulation Law of Combating Narcotics Drugs and Psychotropic Substances," which outlines procedures for importing controlled substances, and the "Registration Rules of Pharmaceutical, Herbal and Health Product Manufacturers and their Products Guideline," which provides detailed requirements for product registration. (sfda.gov.sa)

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Saudi Arabia are stringent. Importers must obtain an import license from the SFDA, which is typically valid for one year and renewable upon meeting specific conditions. The application process involves submitting detailed information about the product, including its generic and commercial names, dosage forms, concentrations, packaging, and quantities. (sfda.gov.sa)

Regarding Good Manufacturing Practice (GMP) certification, the SFDA recognizes GMP certificates from countries with established regulatory frameworks, such as the European Union (EU), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Manufacturers from these regions are generally accepted without the need for additional inspections, provided they meet the SFDA's standards. (sfda.gov.sa)

S T C Salehiya Trading — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

S T C Salehiya Trading's focus on importing advanced antibiotics and oncology medications aligns with the growing demand for specialized treatments in Saudi Arabia. The Kingdom has been experiencing an increase in antibiotic-resistant infections and a rising incidence of cancer, necessitating the availability of effective and innovative therapies. By concentrating on these therapeutic areas, S T C Salehiya Trading addresses critical healthcare needs and positions itself as a key supplier of essential medications.

The company's import strategy is driven by market demand for high-quality, specialized pharmaceutical products. By sourcing these products from reputable manufacturers like Venus Remedies Limited, S T C Salehiya Trading ensures a consistent supply of effective treatments, thereby contributing to the overall improvement of healthcare outcomes in Saudi Arabia.

2Sourcing Profile

S T C Salehiya Trading's sourcing strategy is centered on importing generic pharmaceutical formulations, primarily from India. This approach allows the company to offer cost-effective medications without compromising on quality. India's well-established pharmaceutical industry, known for its adherence to international GMP standards, makes it a reliable source for generic drugs.

The company's preference for finished formulations over raw Active Pharmaceutical Ingredients (APIs) indicates a focus on ready-to-market products, streamlining the supply chain and reducing the time to market. This strategy also ensures that the products meet the SFDA's quality and regulatory requirements, facilitating smoother importation and distribution processes.

Seller's Guide — How to Become a Supplier to S T C Salehiya Trading

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with S T C Salehiya Trading, especially if they can offer products that complement the existing portfolio. For instance, introducing generic formulations of other essential antibiotics or oncology drugs not currently sourced

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — S T C Salehiya Trading

What products does S T C Salehiya Trading import from India?

S T C Salehiya Trading imports 3 pharmaceutical products across 2 categories. Top imports: Meropenem ($1.4M), Dacarbazine ($91.2K), Bleomycin ($81.5K).

Who supplies pharmaceuticals to S T C Salehiya Trading from India?

S T C Salehiya Trading sources from 1 verified Indian suppliers. The primary supplier is Venus Remedies Limited (100.0% of imports, $1.6M).

What is S T C Salehiya Trading's total pharmaceutical import value?

S T C Salehiya Trading's total pharmaceutical import value from India is $1.6M, based on 51 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does S T C Salehiya Trading focus on?

S T C Salehiya Trading imports across 2 categories. The largest: Advanced Antibiotics (89.0%), Advanced Oncology (11.0%).

Get Full S T C Salehiya Trading Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.